Avita Therapeutics Inc (NASDAQ:RCEL)

23.41
Delayed Data
As of Oct 23
 -0.02 / -0.09%
Today’s Change
20.00
Today|||52-Week Range
55.35
-48.55%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Avita Therapeutics Inc have a median target of 41.00, with a high estimate of 60.00 and a low estimate of 5.88. The median estimate represents a +75.14% increase from the last price of 23.41.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Avita Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$5.1M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 55.42%
 
 
 
Growthannually 42.42%
 
 
 
 
 
 

Sales

Growthquarterly 31.55%
 
 
 
 
 
 
Growthannually 60.18%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.